Blue Ghost: The Commercial Moon Lander Achieves Lunar Soft Landing

On 2 March 2025, Blue Ghost, the moon lander built by the private company Firefly Aerospace touched down safely on lunar surface near a volcanic feature called Mons Latreille within Mare Crisium, a more than 300-mile-wide basin located in the northeast quadrant of the Moon’s near side. The lander is in an upright and stable configuration.  

This is the first instance of a commercial spacecraft executing a successful soft landing on the moon.  

The Blue Ghost lander carries a suite of NASA science and technology instruments and is scheduled to conduct experiments on the lunar surface for approximately one lunar day, or about 14 Earth days.  

This lunar delivery is part of NASA’s Commercial Lunar Payload Services (CLPS) initiative and Artemis campaign. This is the first CLPS delivery for Firefly Aerospace.  

NASA’s Commercial Lunar Payload Services (CLPS) initiative was started to promote innovation and growth of private space industry and to reduce cost and to accelerate lunar exploration towards Artemis mission. Under this programme, NASA contracts transportation services to American companies through competitive bidding. To date, five vendors have been awarded contracts for 11 lunar deliveries under CLPS initiative involving sending of more than 50 instruments to various locations on the Moon, including the lunar South Pole. 

NASA’s ‘Commercialisation’ efforts have taken concrete shape with the successful landing of Blue Ghost. It has paved the way for future commercial missions to the Moon and Mars. 

*** 

References:  

  1. NASA. Touchdown! Carrying NASA Science, Firefly’s Blue Ghost Lands on Moon. Posted 2 March 2025. Available at https://www.nasa.gov/news-release/touchdown-carrying-nasa-science-fireflys-blue-ghost-lands-on-moon/  
  1. Blue Ghost Mission 1: Live Updates 4 March 2025.Available at https://fireflyspace.com/news/blue-ghost-mission-1-live-updates/  
  1. Blue Ghost https://fireflyspace.com/blue-ghost/  

*** 

Related article  

*** 

Latest

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Newsletter

Don't miss

Oxford/AstraZeneca COVID-19 Vaccine (ChAdOx1 nCoV-2019) Found Effective and Approved

Interim data from the phase III clinical trial of...

Drug De Addiction: New Approach to Curb Drug Seeking Behaviour

Breakthrough study shows that cocaine craving can be successfully...

Neuralink: A Next Gen Neural Interface That Could Change Human Lives

Neuralink is an implantable device that has shown significant...

Sustainable Agriculture: Economic and Environmental Conservation for Smallholding Farmers

A recent report shows a sustainable agriculture initiative in...

Perseverance: What is so Special About the Rover of NASA’s Mission Mars 2020

NASA’s ambitious mars mission Mars 2020 was successfully launched on 30...

Sotrovimab Approval in the UK: A Monoclonal Antibody Effective Against Omicron, may work for Future Variants as well

Sotrovimab, a monoclonal antibody already approved for mild to...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

I agree to these terms.